131262397	131262397	CD	B-NP	O
|	|	NNP	I-NP	O
RH	RH	NNP	I-NP	O
|	|	VBD	B-VP	O
01631967	01631967	CD	B-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
5402452	5402452	CD	B-NP	O
|	|	CC	I-NP	O
9/19/2005	9/19/2005	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-cell_type
SMALL	SMALL	NNP	I-NP	I-cell_type
BOWEL	BOWEL	NNP	I-NP	O
OBSTRUCTION	OBSTRUCTION	NNP	I-NP	O
|	|	NNP	I-NP	O
Signed	Signed	NNP	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
9/19/2005	9/19/2005	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
11/22/2006	11/22/2006	CD	B-NP	O
ATTENDING	ATTENDING	NN	I-NP	O
:	:	:	O	O
DEMMER	DEMMER	NN	B-NP	O
,	,	,	O	O
ROBT	ROBT	NNP	B-NP	O
MD	MD	NNP	I-NP	O
PRIMARY	PRIMARY	NNP	I-NP	O
CARE	CARE	NNP	I-NP	O
PHYSICIAN	PHYSICIAN	NNP	I-NP	O
:	:	:	O	O
Dustin	Dustin	NNP	B-NP	O
Theurer	Theurer	NNP	I-NP	O
,	,	,	O	O
MD	MD	NNP	B-NP	O
CARDIOLOGIST	CARDIOLOGIST	NNP	I-NP	O
:	:	:	O	O
Hassan	Hassan	NNP	B-NP	O
Gowins	Gowins	NNP	I-NP	O
,	,	,	O	O
MD	MD	NNP	B-NP	O
GASTROENTEROLOGIST	GASTROENTEROLOGIST	NNP	I-NP	O
:	:	:	O	O
Coy	Coy	NNP	B-NP	O
Spurgers	Spurger	NNPS	I-NP	O
,	,	,	O	O
MD	MD	NNP	B-NP	O
PRINCIPAL	PRINCIPAL	NNP	I-NP	O
DIAGNOSES	DIAGNOSES	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

Small-bowel	Small-bowel	JJ	B-NP	O
obstruction	obstruction	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Congestive	Congestive	JJ	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Dilated	Dilate	VBN	B-NP	O
idiopathic	idiopathic	JJ	I-NP	O
cardiomyopathy	cardiomyopathy	NN	I-NP	O
.	.	.	O	O

LIST	LIST	NN	B-NP	B-protein
OF	OF	IN	B-PP	I-protein
PROBLEMS/DIAGNOSES	PROBLEMS/DIAGNOSES	NNPS	B-NP	B-protein
:	:	:	O	I-protein
1	1	LS	B-LST	I-protein
.	.	.	O	O

Dilated	Dilate	VBN	B-NP	O
cardiomyopathy	cardiomyopathy	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Diabetes	Diabetes	NN	B-NP	O
type	type	NN	I-NP	O
2	2	CD	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Ulcerative	Ulcerative	JJ	B-NP	O
colitis	colitis	NN	I-NP	O
,	,	,	O	O
status	status	NN	B-NP	O
post	post	NN	I-NP	O
total	total	JJ	I-NP	O
colectomy	colectomy	NN	I-NP	O
with	with	IN	B-PP	O
colostomy	colostomy	NN	B-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Rheumatoid	Rheumatoid	JJ	B-NP	O
arthritis	arthritis	NN	I-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Chronic	Chronic	JJ	B-NP	O
renal	renal	JJ	I-NP	O
insufficiency	insufficiency	NN	I-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Pyoderma	Pyoderma	NN	B-NP	O
gangrenosum	gangrenosum	NN	I-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

Sundowning	Sundowne	VBG	B-VP	O
.	.	.	O	O

HISTORY	HISTORY	NN	B-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
Mrs.	Mrs.	NNP	B-NP	O
Aswegan	Aswegan	NNP	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
74-year-old	74-year-old	JJ	I-NP	O
woman	woman	NN	I-NP	O
,	,	,	O	O
recently	recently	RB	B-VP	O
admitted	admit	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Kimonte	Kimonte	NNP	I-NP	O
on	on	IN	B-PP	O
1/14/05	1/14/05	CD	B-NP	O
for	for	IN	B-PP	O
CHF	CHF	NN	B-NP	O
exacerbation	exacerbation	NN	I-NP	O
and	and	CC	I-NP	O
UTI	UTI	NN	I-NP	B-protein
-LRB-	-LRB-	HYPH	B-NP	O
Gram-negative	Gram-negative	JJ	I-NP	O
rods	rod	NNS	I-NP	O
,	,	,	O	O
Klebsiella	Klebsiella	NNP	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
who	who	WP	B-NP	O
presents	present	VBZ	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Vide	Vide	NNP	I-NP	O
Tutenoke	Tutenoke	NNP	I-NP	O
Rahbrier	Rahbrier	NNP	I-NP	O
Healthcare	Healthcare	NNP	I-NP	O
with	with	IN	B-PP	O
one	one	CD	B-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
abdominal	abdominal	JJ	B-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
nausea	nausea	NN	B-NP	O
,	,	,	O	O
vomiting	vomiting	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
decreased	decrease	VBD	B-VP	O
ostomy	ostomy	NN	B-NP	O
output	output	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
multiple	multiple	JJ	B-NP	O
abdominal	abdominal	JJ	I-NP	O
surgeries	surgery	NNS	I-NP	O
including	include	VBG	B-PP	O
a	a	DT	B-NP	O
total	total	JJ	I-NP	O
colectomy	colectomy	NN	I-NP	O
for	for	IN	B-PP	O
ulcerative	ulcerative	JJ	B-NP	O
colitis	colitis	NN	I-NP	O
with	with	IN	B-PP	O
colostomy	colostomy	NN	B-NP	O
,	,	,	O	O
ventral	ventral	JJ	B-NP	O
hernia	hernia	NN	I-NP	O
repairs	repair	NNS	I-NP	O
in	in	IN	B-PP	O
1998	1998	CD	B-NP	O
,	,	,	I-NP	O
2003	2003	CD	I-NP	O
,	,	,	O	O
and	and	CC	O	O
2004	2004	CD	B-NP	O
,	,	,	O	O
revision	revision	NN	B-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
colostomy	colostomy	NN	I-NP	O
in	in	IN	B-PP	O
1996	1996	CD	B-NP	O
,	,	,	I-NP	O
1997	1997	CD	I-NP	O
,	,	,	O	O
and	and	CC	O	O
2003	2003	CD	B-NP	O
.	.	.	O	O

As	As	IN	B-PP	O
a	a	DT	B-NP	O
result	result	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
has	have	VBZ	B-VP	O
had	have	VBN	I-VP	O
a	a	DT	B-NP	O
chronic	chronic	JJ	I-NP	O
left	leave	VBD	B-VP	O
lower	low	JJR	B-NP	O
quadrant	quadrant	JJ	I-NP	O
hernia	hernia	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
denies	deny	VBZ	B-VP	O
any	any	DT	B-NP	O
recent	recent	JJ	I-NP	O
fevers	fever	NNS	I-NP	O
,	,	,	O	O
chills	chill	NNS	B-NP	O
,	,	,	O	O
melena	melena	NN	B-NP	O
,	,	,	O	O
or	or	CC	O	O
hematochezia	hematochezia	NN	B-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
ostomy	ostomy	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
stable	stable	JJ	B-NP	O
dyspnea	dyspnea	NN	I-NP	O
on	on	IN	B-PP	O
exertion	exertion	NN	B-NP	O
after	after	IN	B-PP	O
12	12	CD	B-NP	O
feet	foot	NNS	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
uses	use	VBZ	B-VP	O
a	a	DT	B-NP	O
walker	walker	NN	I-NP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
denies	deny	VBZ	B-VP	O
PND	PND	NN	B-NP	B-protein
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
two-pillow	two-pillow	JJ	B-NP	O
orthopnea	orthopnea	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
had	have	VBN	I-VP	O
stable	stable	JJ	B-NP	O
lower	low	JJR	I-NP	O
extremity	extremity	NN	I-NP	O
edema	edema	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
past	past	JJ	I-NP	O
day	day	NN	I-NP	O
and	and	CC	O	O
no	no	DT	B-NP	O
dysuria	dysuria	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
also	also	RB	B-ADVP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
dilated	dilated	JJ	I-NP	O
idiopathic	idiopathic	JJ	I-NP	O
cardiomyopathy	cardiomyopathy	NN	I-NP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
EF	EF	NN	I-NP	O
of	of	IN	B-PP	O
15	15	CD	B-NP	O
to	to	TO	I-NP	O
20	20	CD	I-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
MI	MI	NN	B-NP	B-protein
20	20	CD	B-NP	I-protein
years	year	NNS	I-NP	I-protein
ago	ago	RB	B-ADVP	O
,	,	,	O	O
diabetes	diabetes	NN	B-NP	O
mellitus	mellitus	NN	I-NP	O
type	type	NN	I-NP	O
2	2	CD	I-NP	O
,	,	,	O	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
chronic	chronic	JJ	B-NP	O
renal	renal	JJ	I-NP	O
insufficiency	insufficiency	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
baseline	baseline	NN	I-NP	O
creatinine	creatinine	NN	I-NP	O
of	of	IN	B-PP	O
approximately	approximately	RB	B-NP	O
1.8	1.8	CD	I-NP	O
to	to	TO	B-PP	O
2	2	CD	B-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
the	the	DT	B-NP	O
emergency	emergency	NN	I-NP	O
room	room	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
2	2	CD	B-NP	O
mg	mg	NN	I-NP	O
of	of	IN	B-PP	O
Dilaudid	Dilaudid	NN	B-NP	B-protein
IV	IV	CD	I-NP	I-protein
for	for	IN	B-PP	O
pain	pain	NN	B-NP	O
plus	plus	CC	O	O
another	another	DT	B-NP	O
1	1	CD	I-NP	O
mg	mg	NN	I-NP	O
IV	IV	CD	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
Zofran	Zofran	NN	B-NP	B-protein
1	1	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
IV	IV	CD	I-NP	I-protein
.	.	.	O	O

An	An	DT	B-NP	O
NG	NG	NN	I-NP	O
tube	tube	NN	I-NP	O
was	be	VBD	B-VP	O
placed	place	VBN	I-VP	O
,	,	,	O	O
and	and	CC	O	O
hooked	hook	VBD	B-VP	O
to	to	TO	B-PP	O
suction	suction	NN	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
drained	drain	VBD	B-VP	O
1	1	CD	B-NP	O
liter	liter	NN	I-NP	O
of	of	IN	B-PP	O
green	green	JJ	B-NP	O
fluid	fluid	NN	I-NP	O
that	that	WDT	B-NP	O
was	be	VBD	B-VP	O
guaiac	guaiac	NN	B-NP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

CT	CT	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
abdomen	abdomen	NN	I-NP	O
and	and	CC	I-NP	O
pelvis	pelvis	NN	I-NP	O
showed	show	VBD	B-VP	O
high-grade	high-grade	JJ	B-NP	O
small-bowel	small-bowel	JJ	I-NP	O
obstruction	obstruction	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
transition	transition	NN	I-NP	O
point	point	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
lower	low	JJR	I-NP	O
quadrant	quadrant	NN	I-NP	O
hernia	hernia	NN	I-NP	O
,	,	,	O	O
dilated	dilate	VBN	B-VP	O
small-bowel	small-bowel	JJ	B-NP	O
loops	loop	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
fat	fat	JJ	B-NP	O
stranding	stranding	NN	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
second	second	JJ	I-NP	O
radiologist	radiologist	NN	I-NP	O
per	per	IN	B-PP	O
the	the	DT	B-NP	O
surgical	surgical	JJ	I-NP	O
note	note	NN	I-NP	O
said	say	VBD	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
transition	transition	NN	I-NP	O
point	point	NN	I-NP	O
may	may	MD	B-VP	O
have	have	VB	I-VP	O
actually	actually	RB	I-VP	O
been	be	VBN	I-VP	O
distal	distal	JJ	B-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
hernia	hernia	NN	I-NP	O
and	and	CC	O	O
may	may	MD	B-VP	O
have	have	VB	I-VP	O
been	be	VBN	I-VP	O
located	located	JJ	B-ADJP	O
within	within	IN	B-PP	O
the	the	DT	B-NP	O
pelvis	pelvis	NN	I-NP	O
.	.	.	O	O

After	After	IN	B-PP	O
surgical	surgical	JJ	B-NP	O
evaluation	evaluation	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
floor	floor	NN	I-NP	O
for	for	IN	B-PP	O
conservative	conservative	JJ	B-NP	O
medical	medical	JJ	I-NP	O
management	management	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
small-bowel	small-bowel	JJ	I-NP	O
obstruction	obstruction	NN	I-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

Admission	Admission	NN	B-NP	O
on	on	IN	B-PP	O
1/14/05	1/14/05	CD	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Manben	Manben	NNP	I-NP	O
Valley	Valley	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
for	for	IN	B-PP	O
CHF	CHF	NNP	B-NP	O
exacerbation	exacerbation	NN	I-NP	O
and	and	CC	I-NP	O
UTI	UTI	NN	I-NP	B-DNA
,	,	,	O	O
discharged	discharge	VBN	B-VP	O
on	on	IN	B-PP	O
7/6/05	7/6/05	CD	B-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Admission	Admission	NN	B-NP	O
to	to	TO	B-PP	O
Glen	Glen	NNP	B-NP	O
Barboaks	Barboaks	NNP	I-NP	O
Memorial	Memorial	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
Of	Of	NNP	I-NP	O
County	County	NNP	I-NP	O
in	in	IN	B-PP	O
September	September	NNP	B-NP	O
of	of	IN	B-PP	O
2005	2005	CD	B-NP	O
for	for	IN	B-PP	O
CHF	CHF	NN	B-NP	O
exacerbation	exacerbation	NN	I-NP	O
and	and	CC	O	O
acute	acute	JJ	B-NP	O
renal	renal	JJ	I-NP	O
failure	failure	NN	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Admissions	Admission	NNS	B-NP	O
in	in	IN	B-PP	O
February	February	NNP	B-NP	O
and	and	CC	I-NP	O
September	September	NNP	I-NP	O
of	of	IN	B-PP	O
2005	2005	CD	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Onore	Onore	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
,	,	,	O	O
one	one	CD	B-NP	O
admission	admission	NN	I-NP	O
status	status	NN	I-NP	O
post	post	NN	I-NP	O
hyperkalemic	hyperkalemic	JJ	I-NP	O
arrest	arrest	NN	I-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Nonischemic	Nonischemic	JJ	B-NP	O
dilated	dilated	JJ	I-NP	O
cardiomyopathy	cardiomyopathy	NN	I-NP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
EF	EF	NN	I-NP	O
of	of	IN	B-PP	O
15	15	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
an	an	DT	B-NP	O
echo	echo	JJ	I-NP	O
dated	dated	JJ	I-NP	O
September	September	NNP	I-NP	O
of	of	IN	B-PP	O
2005	2005	CD	B-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
Medmar	Medmar	NNP	I-NP	O
&	&	CC	I-NP	O
Tahry	Tahry	NNP	I-NP	O
Genglo	Genglo	NNP	I-NP	O
Medical	Medical	NNP	I-NP	O
Center	Center	NNP	I-NP	O
,	,	,	O	O
dry	dry	JJ	B-NP	O
weight	weight	NN	I-NP	O
of	of	IN	B-PP	O
approximately	approximately	RB	B-NP	O
130	130	CD	I-NP	O
pounds	pound	NNS	I-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Coronary	Coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

MI	MI	NN	B-NP	O
20	20	CD	B-NP	O
years	year	NNS	I-NP	O
ago	ago	RB	B-ADVP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

Diabetes	Diabetes	NN	B-NP	O
mellitus	mellitus	NN	I-NP	O
type	type	NN	I-NP	O
2	2	CD	I-NP	O
.	.	.	O	O

8	8	CD	B-NP	O
.	.	.	O	O

Ulcerative	Ulcerative	JJ	B-NP	O
colitis	colitis	NN	I-NP	O
,	,	,	O	O
status	status	NN	B-NP	B-protein
post	post	NN	I-NP	I-protein
total	total	JJ	I-NP	I-protein
colectomy	colectomy	NN	I-NP	I-protein
50	50	CD	B-NP	I-protein
years	year	NNS	I-NP	I-protein
ago	ago	RB	B-ADVP	O
with	with	IN	B-PP	O
multiple	multiple	JJ	B-NP	O
revisions	revision	NNS	I-NP	O
.	.	.	O	O

9	9	CD	B-NP	O
.	.	.	O	O

Ventral	Ventral	JJ	B-NP	O
hernia	hernia	NN	I-NP	O
repair	repair	NN	I-NP	O
,	,	,	O	O
twice	twice	RB	B-ADVP	O
with	with	IN	B-PP	O
mesh	mesh	NN	B-NP	O
.	.	.	O	O

10	10	CD	B-NP	O
.	.	.	O	O

DJD	DJD	NN	B-NP	O
.	.	.	O	O

11	11	CD	B-NP	O
.	.	.	O	O

RA	RA	NN	B-NP	O
.	.	.	O	O

12	12	CD	B-NP	O
.	.	.	O	O

CRI	CRI	NN	B-NP	O
.	.	.	O	O

13	13	CD	B-NP	O
.	.	.	O	O

Pyoderma	Pyoderma	NN	B-NP	O
gangrenosum	gangrenosum	NN	I-NP	O
.	.	.	O	O

ALLERGIES	ALLERGIES	NNS	B-NP	O
:	:	:	O	O
Sulfa	Sulfa	NN	B-NP	O
and	and	CC	I-NP	O
penicillin	penicillin	NN	I-NP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
ON	ON	NN	I-NP	O
ADMISSION	ADMISSION	NN	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Aspirin	Aspirin	NN	B-NP	O
81	81	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
24h	24h	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Torsemide	Torsemide	NN	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
12h	12h	NN	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

K-Dur	K-Dur	NN	B-NP	O
20	20	CD	I-NP	O
mEq	mEq	NN	I-NP	O
.	.	.	O	O

p.o.	p.o.	LS	B-NP	O
q.	q.	NN	I-NP	O
24h	24h	NN	I-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Levofloxacin	Levofloxacin	NN	B-NP	O
250	250	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
24h	24h	NN	I-NP	O
.	.	.	O	O

x3	x3	CD	B-NP	O
days	day	NNS	I-NP	O
-LRB-	-LRB-	SYM	B-NP	O
7/6/05	7/6/05	CD	I-NP	O
to	to	TO	I-NP	O
7/11/05	7/11/05	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

NPH	NPH	NN	B-NP	B-protein
15	15	CD	I-NP	I-protein
units	unit	NNS	I-NP	I-protein
q.a.m.	q.a.m.	RB	B-ADVP	O
,	,	,	O	O
7	7	CD	B-NP	O
units	unit	NNS	I-NP	O
q.p.m.	q.p.m.	NN	B-NP	O
6	6	CD	I-NP	O
.	.	.	O	O

Magnesium	Magnesium	NNP	B-NP	O
gluconate	gluconate	NN	I-NP	O
500	500	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
24h	24h	NN	I-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

Digoxin	Digoxin	NN	B-NP	O
0.0625	0.0625	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
24h	24h	NN	I-NP	O
.	.	.	O	O

8	8	CD	B-NP	O
.	.	.	O	O

PhosLo	PhosLo	NN	B-NP	O
667	667	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
8h	8h	NN	I-NP	O
.	.	.	O	O

9	9	CD	B-NP	O
.	.	.	O	O

Nexium	Nexium	NN	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
24h	24h	NN	I-NP	O
.	.	.	O	O

10	10	CD	B-NP	O
.	.	.	O	O

Hydralazine	Hydralazine	NN	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
8h	8h	NN	I-NP	O
.	.	.	O	O

11	11	CD	B-NP	O
.	.	.	O	O

Isordil	Isordil	NN	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
8h	8h	NN	I-NP	O
.	.	.	O	O

12	12	CD	B-NP	O
.	.	.	O	O

Carvedilol	Carvedilol	NN	B-NP	O
6.25	6.25	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
12h	12h	NN	I-NP	O
.	.	.	O	O

13	13	CD	B-NP	O
.	.	.	O	O

Ambien	Ambien	IN	B-PP	O
10	10	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.h.s.	q.h.s.	NN	I-NP	O
14	14	CD	I-NP	O
.	.	.	O	O

Gabapentin	Gabapentin	NN	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
q.	q.	NN	I-NP	O
12h	12h	NN	I-NP	O
.	.	.	O	O

15	15	CD	B-NP	O
.	.	.	O	O

Prednisone	Prednisone	NN	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
24h	24h	NN	I-NP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	NN	B-NP	O
EXAMINATION	EXAMINATION	NN	I-NP	O
ON	ON	NN	I-NP	O
ADMISSION	ADMISSION	NN	I-NP	O
:	:	:	O	O
Vital	Vital	JJ	B-NP	O
signs	sign	NNS	I-NP	O
,	,	,	O	O
temperature	temperature	NN	B-NP	B-protein
96.4	96.4	CD	I-NP	I-protein
,	,	,	O	O
pulse	pulse	NN	B-NP	O
84	84	CD	I-NP	O
,	,	,	O	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
132/70	132/70	CD	I-NP	O
,	,	,	I-NP	O
respiratory	respiratory	JJ	I-NP	O
rate	rate	NN	I-NP	O
14	14	CD	I-NP	O
,	,	,	O	O
and	and	CC	O	O
sat	sit	VBD	B-VP	O
97	97	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
room	room	NN	B-NP	O
air	air	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
pale	pale	JJ	B-ADJP	O
,	,	,	O	O
ill	ill	VB	B-VP	O
appearing	appear	VBG	I-VP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
NG	NG	NN	I-NP	O
tube	tube	NN	I-NP	O
in	in	IN	B-PP	O
place	place	NN	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
cardiac	cardiac	JJ	I-NP	O
exam	exam	NN	I-NP	O
revealed	reveal	VBD	B-VP	O
an	an	DT	B-NP	O
S3	S3	NN	I-NP	B-protein
gallop	gallop	NN	I-NP	I-protein
.	.	.	O	O

PMI	PMI	NN	B-NP	B-protein
was	be	VBD	B-VP	O
displaced	displace	VBN	I-VP	O
and	and	CC	O	O
sustained	sustain	VBN	B-VP	O
.	.	.	O	O

Heart	Heart	NN	B-NP	O
rate	rate	NN	I-NP	O
was	be	VBD	B-VP	O
regular	regular	JJ	B-ADJP	O
in	in	IN	B-PP	O
rate	rate	NN	B-NP	O
and	and	CC	I-NP	O
rhythm	rhythm	NN	I-NP	O
.	.	.	O	O

Lungs	Lung	NNS	B-NP	O
were	be	VBD	B-VP	O
clear	clear	JJ	B-ADJP	O
to	to	TO	B-PP	O
auscultation	auscultation	NN	B-NP	O
.	.	.	O	O

Abdomen	Abdoman	NNS	B-NP	O
was	be	VBD	B-VP	O
distended	distend	VBN	I-VP	O
and	and	CC	O	O
tender	tender	NN	B-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
rebound	rebound	NN	I-NP	O
or	or	CC	I-NP	O
guarding	guarding	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
left	leave	VBD	B-VP	O
lower	low	JJR	B-NP	O
quadrant	quadrant	JJ	I-NP	O
hernia	hernia	NN	I-NP	O
was	be	VBD	B-VP	O
approximately	approximately	RB	B-NP	O
15	15	CD	I-NP	O
cm	cm	NN	I-NP	O
in	in	IN	B-PP	O
size	size	NN	B-NP	O
and	and	CC	I-NP	O
reducible	reducible	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
ostomy	ostomy	NN	I-NP	O
was	be	VBD	B-VP	O
without	without	IN	B-PP	O
any	any	DT	B-NP	O
output	output	NN	I-NP	O
.	.	.	O	O

Neurological	Neurological	JJ	B-NP	O
exam	exam	NN	I-NP	O
revealed	reveal	VBD	B-VP	O
no	no	DT	B-NP	O
focal	focal	JJ	I-NP	O
deficits	deficit	NNS	I-NP	O
or	or	CC	O	O
facial	facial	JJ	B-NP	O
droops	droop	NNS	I-NP	O
.	.	.	O	O

OPERATIONS/PROCEDURES	OPERATIONS/PROCEDURES	NNP	B-NP	O
:	:	:	O	O
None	None	NN	B-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	NNP	B-NP	O
COURSE	COURSE	NNP	I-NP	O
BY	BY	NNP	I-NP	O
PROBLEMS	PROBLEMS	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

GI	GI	LS	B-LST	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
presented	present	VBD	B-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
small-bowel	small-bowel	JJ	I-NP	O
obstruction	obstruction	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
point	point	NN	I-NP	O
of	of	IN	B-PP	O
transition	transition	NN	B-NP	O
was	be	VBD	B-VP	O
thought	think	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
pelvis	pelvis	NN	I-NP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
second	second	JJ	I-NP	O
Radiology	Radiology	NN	I-NP	O
opinion	opinion	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
kept	keep	VBN	I-VP	O
n.p.o.	n.p.o.	NN	B-NP	O
,	,	,	O	O
NG	NG	NN	B-NP	O
tube	tube	NN	I-NP	O
to	to	TO	B-PP	O
suction	suction	NN	B-NP	O
.	.	.	O	O

SBO	SBO	NN	B-NP	B-protein
resolved	resolve	VBD	B-VP	O
on	on	IN	B-PP	O
4/4/05	4/4/05	CD	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
abdominal	abdominal	JJ	I-NP	O
exam	exam	NN	I-NP	O
improved	improve	VBD	B-VP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
pain	pain	NN	I-NP	O
improved	improve	VBD	B-VP	O
.	.	.	O	O

At	At	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
ostomy	ostomy	NN	I-NP	O
was	be	VBD	B-VP	O
putting	put	VBG	I-VP	O
out	out	RP	B-PRT	O
green	green	JJ	B-NP	O
stool	stool	NN	I-NP	O
.	.	.	O	O

Lactate	Lactate	NN	B-NP	O
levels	level	NNS	I-NP	O
were	be	VBD	B-VP	O
followed	follow	VBN	I-VP	O
,	,	,	O	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
peak	peak	NN	I-NP	O
of	of	IN	B-PP	O
1.4	1.4	CD	B-NP	O
and	and	CC	O	O
then	then	RB	O	O
back	back	RB	B-ADVP	O
down	down	RB	I-ADVP	O
to	to	TO	B-PP	O
0.8	0.8	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
kept	keep	VBN	I-VP	O
on	on	IN	B-PP	O
an	an	DT	B-NP	O
IV	IV	CD	I-NP	O
proton	proton	NN	I-NP	O
pump	pump	NN	I-NP	O
inhibitor	inhibitor	NN	I-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
switched	switch	VBD	B-VP	O
to	to	TO	I-VP	O
p.o.	p.o.	VB	I-VP	O
.	.	.	O	O

At	At	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
diet	diet	NN	I-NP	O
was	be	VBD	B-VP	O
being	be	VBG	I-VP	O
advanced	advance	VBN	I-VP	O
as	as	IN	B-PP	O
tolerated	tolerate	VBN	B-VP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
tolerating	tolerate	VBG	I-VP	O
a	a	DT	B-NP	O
mechanical	mechanical	JJ	I-NP	O
soft	soft	JJ	I-NP	O
diet	diet	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Cardiovascular	Cardiovascular	JJ	B-ADJP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
CHF	CHF	NN	B-NP	B-protein
with	with	IN	B-PP	O
an	an	DT	B-NP	O
EF	EF	NN	I-NP	O
of	of	IN	B-PP	O
15	15	CD	B-NP	O
to	to	TO	I-NP	O
20	20	CD	I-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
gently	gently	RB	I-VP	O
hydrated	hydrate	VBN	I-VP	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
small-bowel	small-bowel	JJ	I-NP	O
obstruction	obstruction	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
digoxin	digoxin	NN	I-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
beta-blocker	beta-blocker	NN	I-NP	O
was	be	VBD	B-VP	O
switched	switch	VBN	I-VP	O
to	to	TO	B-PP	O
Lopressor	Lopressor	NN	B-NP	B-protein
.	.	.	O	O

Her	Her	PRP$	B-NP	O
diuretics	diuretic	NNS	I-NP	O
were	be	VBD	B-VP	O
held	hold	VBN	I-VP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
hydralazine	hydralazine	NN	I-NP	O
and	and	CC	I-NP	O
Isordil	Isordil	NN	I-NP	O
were	be	VBD	B-VP	O
held	hold	VBN	I-VP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
her	her	PRP$	B-NP	O
aspirin	aspirin	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
event	event	NN	I-NP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
should	should	MD	B-VP	O
go	go	VB	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
operating	operating	NN	I-NP	O
room	room	NN	I-NP	O
.	.	.	O	O

These	These	DT	B-NP	O
were	be	VBD	B-VP	O
added	add	VBN	I-VP	O
back	back	RB	B-ADVP	O
.	.	.	O	O

At	At	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
on	on	IN	B-PP	O
Coreg	Coreg	NN	B-NP	O
,	,	,	O	O
hydralazine	hydralazine	NN	B-NP	O
,	,	,	O	O
Isordil	Isordil	NN	B-NP	O
,	,	,	O	O
digoxin	digoxin	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
aspirin	aspirin	NN	B-NP	O
at	at	IN	B-PP	O
her	her	PRP$	B-NP	O
home	home	NN	I-NP	O
doses	dose	NNS	I-NP	O
.	.	.	O	O

Diuretic	Diuretic	NNP	B-NP	O
can	can	MD	B-VP	O
be	be	VB	I-VP	O
added	add	VBN	I-VP	O
back	back	RB	B-ADVP	O
for	for	IN	B-PP	O
diuresis	diuresis	NN	B-NP	O
,	,	,	O	O
once	once	RB	B-ADVP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
taking	take	VBG	I-VP	O
improved	improve	VBN	B-NP	O
p.o.	p.o.	NN	I-NP	O
's	's	POS	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
several	several	JJ	B-NP	O
runs	run	NNS	I-NP	O
of	of	IN	B-PP	O
V-TAC	V-TAC	NN	B-NP	B-protein
and	and	CC	O	O
frequent	frequent	JJ	B-NP	O
PVCs	PVC	NNS	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
monitor	monitor	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
electrolytes	electrolyte	NNS	I-NP	O
were	be	VBD	B-VP	O
corrected	correct	VBN	I-VP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
potassium	potassium	NN	I-NP	O
of	of	IN	B-PP	O
4	4	CD	B-NP	O
and	and	CC	O	O
magnesium	magnesium	NN	B-NP	O
of	of	IN	B-PP	O
2	2	CD	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
asymptomatic	asymptomatic	JJ	B-ADJP	O
with	with	IN	B-PP	O
these	these	DT	B-NP	O
rhythms	rhythm	NNS	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
heart	heart	NN	I-NP	O
rate	rate	NN	I-NP	O
was	be	VBD	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
90s	90	NNS	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
was	be	VBD	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
110s/50s	110s/50s	CD	I-NP	O
-70	-70	CD	I-NP	O
s	s	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Endocrine	Endocrine	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
15	15	CD	B-NP	O
units	unit	NNS	I-NP	O
of	of	IN	B-PP	O
NPH	NPH	NN	B-NP	O
q.a.m.	q.a.m.	NN	I-NP	O
,	,	,	O	O
7	7	CD	B-NP	O
units	unit	NNS	I-NP	O
of	of	IN	B-PP	O
NPH	NPH	NN	B-NP	B-protein
q.p.m.	q.p.m.	NN	I-NP	I-protein
,	,	,	O	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
a	a	DT	B-NP	O
Regular	Regular	JJ	I-NP	B-protein
Insulin	Insulin	NN	I-NP	I-protein
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
for	for	IN	B-PP	O
very	very	RB	B-NP	O
strict	strict	JJ	I-NP	O
glucose	glucose	NN	I-NP	O
control	control	NN	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
regimen	regimen	NN	I-NP	O
resulted	result	VBD	B-VP	O
in	in	IN	B-PP	O
occasional	occasional	JJ	B-NP	O
episodes	episode	NNS	I-NP	O
of	of	IN	B-PP	O
hypoglycemia	hypoglycemia	NN	B-NP	O
to	to	TO	B-PP	O
33	33	CD	B-NP	O
and	and	CC	I-NP	O
44	44	CD	I-NP	O
respectively	respectively	RB	B-ADVP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
symptomatic	symptomatic	JJ	B-ADJP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
blood	blood	NN	I-NP	O
sugar	sugar	NN	I-NP	O
of	of	IN	B-PP	O
33	33	CD	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
received	receive	VBD	B-VP	O
an	an	DT	B-NP	O
amp	amp	NN	I-NP	O
of	of	IN	B-PP	O
D50	D50	NN	B-NP	B-protein
and	and	CC	O	O
her	her	PRP$	B-NP	O
blood	blood	NN	I-NP	O
sugar	sugar	NN	I-NP	O
improved	improve	VBD	B-VP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
regimen	regimen	NN	I-NP	O
was	be	VBD	B-VP	O
adjusted	adjust	VBN	I-VP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
on	on	IN	B-PP	O
NPH	NPH	NN	B-NP	B-protein
8	8	CD	I-NP	I-protein
units	unit	NNS	I-NP	O
subcu	subcu	NN	I-NP	O
q.a.m.	q.a.m.	NN	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
Regular	Regular	JJ	I-NP	B-protein
Insulin	Insulin	NN	I-NP	I-protein
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
NPH	NPH	NN	I-NP	B-protein
should	should	MD	B-VP	O
be	be	VB	I-VP	O
titrated	titrate	VBN	I-VP	O
as	as	IN	B-PP	O
her	her	PRP$	B-NP	O
oral	oral	JJ	I-NP	O
intake	intake	NN	I-NP	O
improves	improve	VBZ	B-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
on	on	IN	B-PP	O
chronic	chronic	JJ	B-NP	O
prednisone	prednisone	NN	I-NP	O
for	for	IN	B-PP	O
rheumatoid	rheumatoid	JJ	B-NP	O
arthritis	arthritis	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
switched	switch	VBN	I-VP	O
to	to	TO	B-PP	O
hydrocortisone	hydrocortisone	NN	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
IV	IV	CD	B-NP	O
q.	q.	NN	I-NP	O
8h	8h	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
require	require	VB	I-VP	O
a	a	DT	B-NP	O
stressed	stressed	JJ	I-NP	O
dose	dose	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
switched	switch	VBN	I-VP	O
back	back	RB	B-ADVP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
oral	oral	JJ	I-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
prednisone	prednisone	NN	B-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Renal	Renal	JJ	B-ADJP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
phenol	phenol	NN	I-NP	O
on	on	IN	B-PP	O
presentation	presentation	NN	B-NP	O
was	be	VBD	B-VP	O
0.25	0.25	CD	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
creatinine	creatinine	NN	I-NP	O
was	be	VBD	B-VP	O
2.8	2.8	CD	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
elevated	elevate	VBN	I-VP	O
from	from	IN	B-PP	O
her	her	PRP$	B-NP	O
baseline	baseline	NN	I-NP	O
after	after	IN	B-PP	O
discharge	discharge	NN	B-NP	O
at	at	IN	B-PP	O
Ketchwo	Ketchwo	NNP	B-NP	O
of	of	IN	B-PP	O
2.4	2.4	CD	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
creatinine	creatinine	NN	I-NP	O
rose	rise	VBD	B-VP	O
to	to	TO	B-PP	O
3.3	3.3	CD	B-NP	O
and	and	CC	O	O
then	then	RB	B-VP	O
began	begin	VBD	I-VP	O
to	to	TO	I-VP	O
trend	trend	VB	I-VP	O
down	down	RP	B-PRT	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
creatinine	creatinine	NN	I-NP	O
was	be	VBD	B-VP	O
2.4	2.4	CD	B-NP	O
and	and	CC	O	O
then	then	RB	B-NP	O
2.3	2.3	CD	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
acute	acute	JJ	I-NP	O
on	on	IN	B-PP	O
chronic	chronic	JJ	B-NP	O
renal	renal	JJ	I-NP	O
failure	failure	NN	I-NP	O
was	be	VBD	B-VP	O
thought	think	VBN	I-VP	O
to	to	TO	I-VP	O
represent	represent	VB	I-VP	O
dehydration	dehydration	NN	B-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
poor	poor	JJ	B-NP	O
forward	forward	JJ	I-NP	O
flow	flow	NN	I-NP	O
due	due	JJ	B-PP	O
to	to	TO	B-PP	O
third	third	JJ	B-NP	O
spacing	spacing	NN	I-NP	O
and	and	CC	O	O
decreased	decrease	VBD	B-VP	O
intravascular	intravascular	JJ	B-NP	O
volumes	volume	NNS	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
blood	blood	NN	I-NP	O
pressures	pressure	NNS	I-NP	O
tended	tend	VBD	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
low	low	JJ	I-NP	O
side	side	NN	I-NP	O
when	when	WRB	B-ADVP	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
first	first	RB	I-VP	O
admitted	admit	VBN	I-VP	O
.	.	.	O	O

These	These	DT	B-NP	O
improved	improve	VBD	B-VP	O
with	with	IN	B-PP	O
rehydration	rehydration	NN	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
point	point	NN	I-NP	O
where	where	WRB	B-ADVP	O
her	her	PRP$	B-NP	O
home	home	NN	I-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
medications	medication	NNS	I-NP	O
could	could	MD	B-VP	O
be	be	VB	I-VP	O
restarted	restart	VBN	I-VP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

ID	ID	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
levofloxacin	levofloxacin	NN	B-NP	O
500	500	CD	I-NP	O
mg	mg	NN	I-NP	O
IV	IV	CD	B-NP	O
q.4-8h	q.4-8h	NN	I-NP	O
.	.	.	O	O

and	and	CC	O	O
Flagyl	Flagyl	NN	B-NP	O
500	500	CD	I-NP	O
mg	mg	NN	I-NP	O
IV	IV	CD	B-NP	O
q.	q.	NN	I-NP	O
8h	8h	NN	I-NP	O
.	.	.	O	O

for	for	IN	B-PP	O
an	an	DT	B-NP	O
elevated	elevated	JJ	I-NP	O
white	white	JJ	I-NP	O
count	count	NN	I-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
of	of	IN	B-PP	O
14.65	14.65	CD	B-NP	O
with	with	IN	B-PP	O
87.3	87.3	CD	B-NP	O
%	%	NN	I-NP	O
neutrophils	neutrophil	NNS	I-NP	B-cell_type
.	.	.	O	O

Her	Her	PRP$	B-NP	B-cell_line
blood	blood	NN	I-NP	I-cell_line
cultures	culture	NNS	I-NP	I-cell_line
from	from	IN	B-PP	O
6/12/05	6/12/05	CD	B-NP	O
were	be	VBD	B-VP	O
positive	positive	JJ	B-ADJP	O
,	,	,	O	O
two	two	CD	B-NP	O
out	out	IN	I-NP	O
of	of	IN	I-NP	O
four	four	CD	I-NP	O
bottles	bottle	NNS	I-NP	O
in	in	IN	B-PP	O
24	24	CD	B-NP	O
hours	hour	NNS	I-NP	O
for	for	IN	B-PP	O
Gram-positive	Gram-positive	JJ	B-NP	O
cocci	coccus	NNS	I-NP	O
identified	identify	VBN	B-VP	O
as	as	IN	B-PP	O
MRSA	MRSA	NN	B-NP	B-protein
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
vancomycin	vancomycin	NN	B-NP	O
1	1	CD	I-NP	O
gm	gm	NN	I-NP	O
IV	IV	CD	B-NP	O
q.	q.	NN	I-NP	O
48h	48h	NN	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
will	will	MD	B-VP	O
need	need	VB	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
continued	continue	VBN	I-VP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
total	total	NN	I-NP	O
of	of	IN	B-PP	O
two	two	CD	B-NP	O
weeks	week	NNS	I-NP	O
,	,	,	O	O
start	start	NN	B-NP	O
day	day	NN	I-NP	O
6/20/05	6/20/05	CD	B-NP	O
,	,	,	O	O
stop	stop	NN	B-NP	O
day	day	NN	I-NP	O
8/7/06	8/7/06	CD	I-NP	O
.	.	.	O	O

Levofloxacin	Levofloxacin	NN	B-NP	O
and	and	CC	I-NP	O
Flagyl	Flagyl	NN	I-NP	O
were	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
7/11/05	7/11/05	CD	B-NP	O
,	,	,	O	O
stop	stop	NN	B-NP	O
date	date	NN	I-NP	O
4/16/06	4/16/06	CD	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
remained	remain	VBD	B-VP	O
afebrile	afebrile	JJ	B-ADJP	O
and	and	CC	O	O
her	her	PRP$	B-NP	O
bands	band	NNS	I-NP	O
trended	trend	VBD	B-VP	O
down	down	RB	B-ADVP	O
from	from	IN	B-PP	O
a	a	DT	B-NP	O
peak	peak	NN	I-NP	O
of	of	IN	B-PP	O
39	39	CD	B-NP	O
to	to	TO	I-NP	O
3	3	CD	I-NP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-VP	O
discharge	discharge	VB	I-VP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Rheumatologic	Rheumatologic	JJ	B-ADJP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
steroids	steroid	NNS	B-NP	O
for	for	IN	B-PP	O
rheumatoid	rheumatoid	JJ	B-NP	O
arthritis	arthritis	NN	I-NP	O
and	and	CC	O	O
chronic	chronic	JJ	B-NP	O
steroid	steroid	NN	I-NP	O
dependence	dependence	NN	I-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

Neuro	Neuro	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
episodes	episode	NNS	B-NP	O
of	of	IN	B-PP	O
disorientation	disorientation	NN	B-NP	O
,	,	,	O	O
likely	likely	RB	B-ADJP	O
due	due	IN	B-PP	O
to	to	TO	B-PP	O
sundowning	sundowne	VBG	B-VP	O
two	two	CD	B-NP	O
days	day	NNS	I-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-PP	O
placement	placement	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
required	require	VBD	B-VP	O
0.5	0.5	CD	B-NP	O
mg	mg	NN	I-NP	O
of	of	IN	B-PP	O
IV	IV	CD	B-NP	O
Haldol	Haldol	NN	I-NP	O
for	for	IN	B-PP	O
extreme	extreme	JJ	B-NP	O
agitation	agitation	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
also	also	RB	B-ADVP	O
required	require	VBD	B-VP	O
trazodone	trazodone	NN	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.h.s.	q.h.s.	NN	I-NP	O
for	for	IN	B-PP	O
sleep	sleep	NN	B-NP	O
.	.	.	O	O

8	8	CD	B-NP	O
.	.	.	O	O

Physical	Physical	JJ	B-NP	O
therapy	therapy	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
out	out	IN	B-PP	O
of	of	IN	B-PP	O
bed	bed	NN	B-NP	O
to	to	TO	B-PP	O
chair	chair	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
typically	typically	RB	B-ADVP	O
walks	walk	VBZ	B-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
walker	walker	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
will	will	MD	B-VP	O
require	require	VB	I-VP	O
rehabilitation	rehabilitation	NN	B-NP	O
for	for	IN	B-PP	O
improved	improved	JJ	B-NP	O
coordination	coordination	NN	I-NP	O
and	and	CC	I-NP	O
strength	strength	NN	I-NP	O
.	.	.	O	O

9	9	CD	B-NP	O
.	.	.	O	O

Prophylaxis	Prophylaxis	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
on	on	IN	B-PP	O
proton	proton	NN	B-NP	O
pump	pump	NN	I-NP	O
inhibitor	inhibitor	NN	I-NP	O
and	and	CC	I-NP	O
Lovenox	Lovenox	NN	I-NP	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
stay	stay	NN	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
Pending	Pending	NNP	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
remainder	remainder	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
dictation	dictation	NN	I-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
completed	complete	VBN	I-VP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

eScription	eScription	NN	B-NP	O
document	document	NN	I-NP	O
:	:	:	O	O
2-6250918	2-6250918	CD	B-NP	O
CSSten	CSSten	NNP	I-NP	O
Tel	Tel	NNP	I-NP	O
Dictated	Dictated	NNP	I-NP	O
By	By	NNP	I-NP	O
:	:	:	O	O
DREHS	DREHS	NNP	B-NP	O
,	,	,	O	O
WILEY	WILEY	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
HIGGENS	HIGGENS	NN	B-NP	O
,	,	,	O	O
JEREMIAH	JEREMIAH	NNP	B-NP	O
Dictation	Dictation	NNP	I-NP	O
ID	ID	NNP	I-NP	O
9432277	9432277	CD	I-NP	O
D	D	NNP	I-NP	O
:	:	:	O	O
1/2/06	1/2/06	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
8/6/06	8/6/06	CD	B-NP	O

